Intern, Toxicology, NDCP
This job is no longer available
There are still lots of open positions. Let's find the one that's right for you.
About The Position
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding scientists in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. As part of the Toxicology group in the Department of Nonclinical Development and Clinical Pharmacology (NDCP), the Toxicology Intern will collaborate with RevMed toxicologists to support development of safety studies using new bioengineered tissue models and informatics tools to help advance the preclinical safety assessment of RevMed molecules. This internship will provide an opportunity to interact with scientists in a team-driven environment.
